208 related articles for article (PubMed ID: 10741131)
21. Presentation, staging and diagnosis of lymphoma: a clinical perspective.
Hingorjo MR; Syed S
J Ayub Med Coll Abbottabad; 2008; 20(4):100-3. PubMed ID: 19999217
[TBL] [Abstract][Full Text] [Related]
22. Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas.
Rosenberg SA
Cancer Treat Rep; 1977 Sep; 61(6):1023-7. PubMed ID: 902260
[TBL] [Abstract][Full Text] [Related]
23. [Prognosis analysis of 53 cases with primary intestinal non-Hodgkin's lymphoma].
Xiang XJ; He YJ; Li YH; Huang HQ; Xia ZJ; Huang H
Ai Zheng; 2004 Apr; 23(4):443-7. PubMed ID: 15087036
[TBL] [Abstract][Full Text] [Related]
24. Non-Hodgkin's lymphoma. Understanding the disease.
Rahr VA; Tucker R
Cancer Nurs; 1990 Feb; 13(1):56-61. PubMed ID: 2407340
[TBL] [Abstract][Full Text] [Related]
25. [Analysis for clinicopathological features, therapy and prognosis of 30 elderly patients with non-Hodgkin's lymphoma].
Wang HT; Yang B; Cai LL; Ran HH; Zhang WY; Zhu HL; Yang Y; Li SX; Fan H; Chi XH; Yu RL; Zhang F; Li BL; Lin J; Zhai B; Yao SQ; Lu XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1464-70. PubMed ID: 24370030
[TBL] [Abstract][Full Text] [Related]
26. Non-Hodgkin's lymphoma in southeast Turkey: clinicopathologic features of 490 cases.
Isikdogan A; Ayyildiz O; Buyukcelik A; Arslan A; Tiftik N; Buyukbayram H; Muftuoglu E
Ann Hematol; 2004 May; 83(5):265-9. PubMed ID: 15060744
[TBL] [Abstract][Full Text] [Related]
27. [Validity of the International Prognostic Index in non-Hodgkin's lymphomas of varying grades of malignancy].
Bettini R; Caronni F; Maino C; Marzetta K; Sala D; Saccà V; Gorini M
Recenti Prog Med; 2003 Nov; 94(11):494-500. PubMed ID: 14679917
[TBL] [Abstract][Full Text] [Related]
28. Adult lymphomas in Edo state, Niger Delta region of Nigeria--clinicopathological profile of 205 cases.
Omoti CE; Halim NK
Clin Lab Haematol; 2005 Oct; 27(5):302-6. PubMed ID: 16178909
[TBL] [Abstract][Full Text] [Related]
29. International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients.
Navarro JT; Ribera JM; Oriol A; Vaquero M; Romeu J; Batlle M; Gómez J; Millá F; Feliu E
Haematologica; 1998 Jun; 83(6):508-13. PubMed ID: 9676023
[TBL] [Abstract][Full Text] [Related]
30. [Imaging of supradiaphragmatic manifestations of extranodal non-Hodgkin's lymphoma].
Cohnen M; Saleh A; Germing U; Engelbrecht V; Mödder U
Radiologe; 2002 Dec; 42(12):960-9. PubMed ID: 12486550
[TBL] [Abstract][Full Text] [Related]
31. Classification of non-Hodgkin's lymphomas in children.
Perkins SL; Segal GH; Kjeldsberg CR
Semin Diagn Pathol; 1995 Nov; 12(4):303-13. PubMed ID: 8578025
[TBL] [Abstract][Full Text] [Related]
32. [Serum tumor necrosis factor-alpha levels in non-Hodgkin's lymphoma patients and its relationship to prognosis].
Li D; Li G; Wang B
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):293-6. PubMed ID: 11038763
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of early stage primary tonsil non-Hodgkin's lymphoma].
Gao YH; Li YX; Zhao LJ; Yuan ZY; Liu XF; Yu ZH
Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):190-2. PubMed ID: 12864949
[TBL] [Abstract][Full Text] [Related]
34. Pathological classification of non-Hodgkin's lymphoma for epidemiological studies.
Weisenburger DD
Cancer Res; 1992 Oct; 52(19 Suppl):5456s-5462s; discussion 5462s-5464s. PubMed ID: 1394154
[TBL] [Abstract][Full Text] [Related]
35. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
[TBL] [Abstract][Full Text] [Related]
36. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
38. [A clinicopathologic analysis of primary ovarian non-Hodgkin's lymphoma].
Tang QL; Yang KZ; Liu WP; Peng ZL; Li JM; Li GD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):641-3, 655. PubMed ID: 16909622
[TBL] [Abstract][Full Text] [Related]
39. Malignant lymphoma of the head and neck.
Zapater E; Bagán JV; Carbonell F; Basterra J
Oral Dis; 2010 Mar; 16(2):119-28. PubMed ID: 20374502
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic factors and predictive model of non-Hodgkin's lymphoma: pathological prognostic groupings and international prognostic index].
Shimoyama M
Nihon Rinsho; 2000 Mar; 58(3):602-11. PubMed ID: 10741132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
